Horizon Pharma plcHZNP was a big mover last session, as the company saw its shares rise above 6% on the day. The upside came on the company's announcement of updated 2016 Net Sales and Adjusted EBITDA guidance. The company also reviewed the 2020 Long-Range Plan. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $13.12 to $21.00 in the past one-month time frame.
In the last 30 days, the company has seen no estimate revision and the Zacks Consensus Estimate also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Horizon Pharma currently has a Zacks Rank #3 (Hold).
A better-ranked bio-medical/gene stock is Actelion Ltd. ALIOF , which sports a Zacks Rank #1 (Strong Buy).
Is HZNP going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ACTELION LTD (ALIOF): Free Stock Analysis Report
HORIZON PHARMA (HZNP): Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
